Bridford Investments

Bridford Group is a London-based private investment firm that specializes in the life sciences and biotechnology industries. Operating as a family office with a long-term capital outlook, the firm plays a pivotal role in the formation and scaling of high-impact healthcare companies. Bridford is most notably recognized for its foundational role in the creation of Centessa Pharmaceuticals, which was formed through the merger of several Bridford-backed portfolio companies. The firm also held significant early positions in mental health innovators such as Compass Pathways and Atai Life Sciences. Bridford focuses on backing breakthrough science across diverse therapeutic areas, including neuroscience, oncology, and rare diseases. By providing permanent capital, the firm supports its portfolio companies through various stages of development without the constraints of traditional venture capital fund cycles.